alexa Role of Glimepiride Novel Sulfonylurea in the Managemen


Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Role of Glimepiride Novel Sulfonylurea in the Management of Type 2 Diabetes Mellitus

 
To read the full article Peer-reviewed Article PDF image

Abstract

Background: Diabetes mellitus (DM) is probably one of the oldest diseases known to man. The number of people with type 2 DM is increasing in every country with 80% of people with DM living in low- and middle-income countries. Type 2 Diabetes mellitus is the most common form of diabetes mellitus characterized by hyperglycemia, insulin resistance, and relative insulin deficiency. There are many effective treatment options available for the type 2 diabetes mellitus. But sulfonylureas still play a primary role in pharmacologic management of type 2 diabetes. Therefore we evaluated the effect of Glimepiride on fasting blood sugar level in patients of type 2 diabetes mellitus. Objective: To find out the effect of Glimepiride on fasting blood sugar level in type 2 diabetes mellitus Patients. Material & Methods: This study was conducted by the Department of Pharmacology in association with Department of Medicine at Maharishi Markandeshwar Institute of Medical Sciences & Research (MMIMSR), Mullana Ambala. Total 25 patients were selected for the study and these patients were administered Glimepiride in dose range of 1-6 mg/day, for 24 weeks. Statistical Analysis: statistical analysis was done by Student’s “t”- test. Result: During the study it was found that there was a significant reduction in fasting blood sugar score (p<0.05) after 24 weeks. Conclusion: Glimepiride play an important role in type 2 diabetes patients because glimepiride effectively reduced fasting blood sugar.

Keywords

Recommended Journals

Share This Page

Additional Info

Loading
Loading Please wait..
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords